Abiopharma

🔍 Sarvikas Juho (Director)

Company: INSEEGO CORP. (INSG)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 3,686 shares of Common Stock at $14.14 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 254,864.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,159 shares of Common Stock at $14.14 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 250,705.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares withheld to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units (RSUs) granted on December 24, 2025. The RSU grant was previously reported in Table I of the reporting person's Form 4 filed on December 29, 2025. The vesting schedule for the award was subsequently modified from an initial structure of monthly vesting over four years (with one-fourth vesting on the first anniversary of the grant date and 1/48th vesting monthly thereafter) to a quarterly vesting schedule, including a 7.5% acceleration of vesting.
• F2: Represents shares withheld to cover payment of the tax liabilities of the reporting person related to the vesting of shares from a restricted stock unit (RSU) award that was granted on 01/06/2025. The grant of the RSU was previously reported in Table I of reporting person's Form 4 filed on 01/07/2025.The vesting schedule for the award was subsequently modified from an initial structure of monthly vesting over four years (with one-fourth vesting on the first anniversary of the grant date and 1/48th vesting monthly thereafter) to a quarterly vesting schedule, including a 7.5% acceleration of vesting.